EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prolonged QT Interval in HIV-1 Infected Humanized Mice Treated Chronically with Dolutegravir/Tenofovir Disoproxil Fumarate/Emtricitabine

Ali Namvaran iD, Julian V Garcia iD, Mahendran Ramasamy, Kayla Nguyen iD, Farzaneh Tavakkoli Ghazani, Bryan T Hackfort, Prasanta K Dash, Reagan E Fisher iD, Benson Edagwa, Santhi Gorantla, Keshore R Bidasee iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27010519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ali Namvaran und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800, USA. Hauptthemen laut MEDLINE: HIV Infections, Tenofovir, HIV-1, Emtricitabine. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The REPRIEVE Trial recently reported high rates of sudden cardiac death (SCD) middle-aged people living with HIV-1 infection (PWH) using the WHO/NIH-recommended two nucleoside reverse transcriptase inhibitors (NRTIs)/one integrase strand inhibitor (INSTI) regimen to manage HIV-1 viremia. To date, clinically relevant animal models to delineate underlying causes for this remain limited. Here, we assessed if HIV-1-infected NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ humanized mice (Hu-mice) treated with the WHO/NIH-recommended antiretroviral regimen, dolutegravir (DTG, INSTI)/tenofovir disoproxil fumarate (TDF, NRTIs)/emtricitabine (FTC, NRTIs), can recapitulate abnormalities in the ECG and subclinical structural heart disease that serve as harbingers of SCD in middle-aged PWH. HIV-1-infected and uninfected Hu-mice served as controls. After one month of infection (HIV-1ADA), ECG intervals/segments were significantly altered. ECG changes progressively worsened as the duration of untreated infection increased. Treating HIV-1-infected animals with the DTG/TDF/FTC for eight weeks, starting four weeks after infection, prevented worsening, but did not restore ECG intervals/segments to those before infection. In hearts from DTG/TDF/FTC-treated animals, steady-state levels of the sarco-(endo) plasmic reticulum Ca2+ ATPase (SERCA2) were reduced by 35%. Steady-state levels of type 2 ryanodine receptor (RyR2) did not change, but its phosphorylation status at Ser2808 was 2-fold higher than that of uninfected controls, indicative of a gain-of-function. The density of perfused micro vessels and fibrosis in hearts of DTG/TDF/FTC-treated animals was not significantly different from that of HIV-1-infected and uninfected Hu-mice. These data show for the first time that HIV-1 infection is triggering abnormalities in the ECG of Hu-mice, and changes in ECG persisted with DTG/TDF/FTC treatment, independent of ischemia and/or fibrosis. They also indicate that chronic DTG/TDF/FTC treatment did not worsen ECG changes, including the QT interval. Since phosphorylation of RyR2 at Ser2808 occurs via β-adrenergic activation of protein kinase A, these new data also suggest that chronic hyperadrenergic activity may be increasing the risk of SCD via Ca2+ leak through RyR2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsTenofovirHIV-1EmtricitabineAnti-HIV AgentsLong QT SyndromeHeterocyclic CompoundsAnimalsDolutegravirMicePiperazinesPyridonesElectrocardiographyOxazinesHumansDisease Models, AnimalMice, Inbred NOD

Stichwörter der Autor:innen

HIV-1QT intervalantiretroviral therapyarrhythmiaelectrocardiographyhumanized micesudden cardiac death

Substanzen

DolutegravirPiperazinesTenofovirPyridonesEmtricitabineOxazinesAnti-HIV AgentsHeterocyclic Compounds

Autor:innen und Institutionen

  • Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800, USA.
  • Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68198-5800, USA.

ORCID-Profile: Ali Namvaran, Julian V Garcia, Kayla Nguyen, Reagan E Fisher, Keshore R Bidasee

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Institute of Health

Zitieren

APA

Namvaran, A., Garcia, J. V., Ramasamy, M., Nguyen, K., Tavakkoli Ghazani, F., Hackfort, B. T., Dash, P. K., Fisher, R. E., Edagwa, B., Gorantla, S., & Bidasee, K. R. (2026). Prolonged QT Interval in HIV-1 Infected Humanized Mice Treated Chronically with Dolutegravir/Tenofovir Disoproxil Fumarate/Emtricitabine. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010519

Vancouver

Namvaran A, Garcia JV, Ramasamy M, Nguyen K, Tavakkoli Ghazani F, Hackfort BT, et al. Prolonged QT Interval in HIV-1 Infected Humanized Mice Treated Chronically with Dolutegravir/Tenofovir Disoproxil Fumarate/Emtricitabine. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27010519

BibTeX
@article{Namvaran2026,
  author = {Namvaran, Ali and Garcia, Julian V and Ramasamy, Mahendran and Nguyen, Kayla and Tavakkoli Ghazani, Farzaneh and Hackfort, Bryan T and Dash, Prasanta K and Fisher, Reagan E and Edagwa, Benson and Gorantla, Santhi and Bidasee, Keshore R},
  title = {Prolonged QT Interval in HIV-1 Infected Humanized Mice Treated Chronically with Dolutegravir/Tenofovir Disoproxil Fumarate/Emtricitabine},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27010519}
}
Kostenlos starten →